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Dr Y. Joseph Woo (Philadelphia, Pa). I congratulate you on
some fantastic large animal work and a creative model. My ques-
tion relates to your choice of a single S-L line and 3 points along
that line for evaluating the unique plane for your tenting area. That
is valid in a planar ring, but in a radically nonplanar surface, the
point you have chosen is sort of a high point in the GeoForm
ring and therefore does not represent the geometry of the tenting
area to the left and right of the posterior midpoint. Would it be
markedly different if you integrated across, say, 3 vertical lines,
maybe one through the middle and then one perhaps 1 cm to the
right and 1 cm to the left?
Dr Bothe. You are absolutely right that annuloplasty rings, es-
pecially the IMR ETLogix, which is asymmetrically designed,
could affect tenting areas in different regions differently. However,
our analyses depend on our marker placement. Because we did not
place markers on the posterior leaflet in the meridians you men-
tioned, we cannot determine such changes at this point. It would
include an interesting future analysis.
Dr Eugene Grossi (New York, NY). A wonderful experiment.
Just a question on your experimental design. Why did you choose
a true-size Physio ring? All clinical expertise and use of this ring
is in downsizing, and if that is the case, you could think that there
are no differences if you just use a ring that gives you a fair
amount of S-L shortening to make the subject more ischemia-re-
sistant.
Dr Bothe. It would be desirable to have an additional animal
group that received downsized Physio rings. In this experiment
we chose to use rings that had similar nominal sizes because that
allowed us to get an impression about the magnitude of changes
of disease-specific rings compared with the Physio ring. Forery c February 2011
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of a downsized Physio and would be similar to an IMR ETLogix or
a GeoForm.
DrRakesh Suri (Rochester, Minn). Can you share any informa-
tion regarding the echocardiographic findings? Did the differences
in mitral tenting correspond to persistence of MR? What is your
hypothesis regarding the effectiveness of ring-induced annular re-
shaping in preventing recurrence of MR in the setting of chronic
ischemia where we know there is progressive and ongoing remod-
eling of the ventricle?
Dr Bothe. To answer your first question regarding the MR
grades, all MR grades increased without a ring implanted, meaning
from baseline to ischemia with no ring inserted, all animals devel-
oped MR and the MR grades were significantly higher. All rings
(Physio, IMR ETLogix, and GeoForm) eliminated the occurrence
of acute MR style.
Dr Suri. All rings?
Dr Bothe. Yes, all rings. As for the chronic setting, I agree with
you that chronic IMR may affect leaflet geometry differently; for
example, this has been shown by Gorman and colleagues in
a chronic experimental setting [Gorman JH III, Gorman RC, Jack-
son BM, Enomoto Y, St John-Sutton MG, Edmunds LH Jr. Annu-
loplasty ring selection for chronic ischemic mitral regurgitation:
lessons from the ovine model. Ann Thorac Surg. 2003;76:1556-
63]. To get an impression about the effects of acute ischemia on
papillary muscle geometry in our acute experimental setup, we
looked at ventricular changes and papillary muscle displacement.
The papillarymuscles displaced by approximately 7mm in the pos-
terolateral direction, which is close to a chronic scenario, but not
identical. So although wewould expect changes in the chronic sce-
nario to be similar, it could well be that they are slightly different.
Dr John Ikonomidis (Charleston, SC). In the setting of this
acute regional ischemic model, what are the physical determinantsThe Journal of Thoracic and Caof mitral leaflet tenting? Why does it occur? What are the things at
play?
Dr Bothe. Pretty much all components of the mitral valve com-
plex can be involved in the pathophysiology of IMR. However, the
major physical determinants in our acute model included mitral
annular dilatation, LV dilatation, and a displacement of the
papillary muscles, mainly the posteromedial papillary muscle.
Dr Ikonomidis. So what you are measuring is actually area
under a flat plane on the annulus, and we need to quantify mitral
leaflet tenting.
Dr Bothe. Yes.
Dr Ikonomidis. How are you modifying that area with these
rings? Are you just bringing the leaflets closer together?
Dr Bothe. That is a good question, because the tenting area is
basically a function of mitral annular dimension and the leaflet sur-
face. We know that the GeoForm decreases the mitral annular S-L
dimension to a greater extent than the IMRETLogix. However, our
data suggest that radical S-L downsizing could induce leaflet
displacements and increased leaflet tethering that, in turn, may
prevent a further reduction in tenting area.
Dr Ikonomidis. So does reduction in the S-L dimension
directly result in modification of papillary muscle displacement?
Dr Bothe. It could enhance leaflet tethering, but it does not nec-
essarily affect the position of the papillary muscle. We will look at
rings effects on the papillary muscles in a future analysis.
Dr Ikonomidis. My point being that it sounds as though with
these rings you are not modifying the direct primary cause of..
Dr Bothe. That is correct.
Dr Ikonomidis. And that raises the question of durability of
these repairs despite functional improvement acutely.
Dr Bothe. Yes, I think our data even provide certain evidence
that it may not be sufficient to treat IMR solely on an annular
level.rdiovascular Surgery c Volume 141, Number 2 353
